| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI00727A022 |
| P698 | PubMed publication ID | 4345806 |
| P2093 | author name string | B Shore | |
| V G Shore | |||
| P2860 | cites work | Group-specific Adsorption of Glycoproteins | Q53992921 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterogeneity | Q928498 |
| P304 | page(s) | 502-507 | |
| P577 | publication date | 1973-01-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components | |
| P478 | volume | 12 |
| Q57816571 | : An Etiologic Agent for Late-Onset Dementia |
| Q39972200 | A study of the interrelationship between the triacylglycerol and protein components of very-low-density lipoproteins using the perfused rat liver |
| Q92927768 | APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology |
| Q41725544 | Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II |
| Q41839705 | Affinity purification and some molecular properties of human liver alkaline phosphatase |
| Q40680901 | An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. |
| Q70454208 | Anion-exchange high-performance liquid chromatography of human serum apolipoproteins |
| Q42001748 | Apo E genotyping in Alzheimer disease (AD): multidimensional counseling by the geriatric assessment unit (GAU) to properly address scientific and bioethical issues emerging from molecular gerontology to geriatric practice |
| Q36804822 | ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation |
| Q36843340 | ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis |
| Q71713135 | Apolipoprotein E and cholesterol metabolism |
| Q34143697 | Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content |
| Q44503147 | Apolipoprotein E-4Philadelphia (Glu13—-Lys,Arg145—-Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia |
| Q40326331 | Apolipoprotein E. |
| Q34415899 | Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway |
| Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
| Q26747482 | Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders |
| Q43138847 | Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. |
| Q40737965 | Apolipoprotein E: structure-function relationships |
| Q40007038 | Apolipoprotein of the low density lipoprotein of human plasma: Structural study in familial hyperbetalipoproteinemia |
| Q34561411 | Apolipoproteins AI, AII, and CI stimulate placental lactogen release from human placental tissue. A novel action of high density lipoprotein apolipoproteins |
| Q24304498 | Apoprotein (E–A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction |
| Q35902081 | Apoprotein composition of very low density lipoproteins of human serum |
| Q39994679 | Apoprotein profile of plasma and chylous ascites lipoproteins |
| Q68330897 | Association of Apolipoprotein E and B Polymorphisms with Serum Lipids |
| Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
| Q39146447 | Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter. |
| Q39967774 | Changes in the apoprotein composition of very low density lipoproteins in man following eating |
| Q40116284 | Changes in the plasma lipoprotein-apoproteins of guinea pigs in response to dietary cholesterol |
| Q42519325 | Characterization of placental lactogen release from perifused human trophoblast cells |
| Q39977944 | Characterization of the ehrlich ascites tumor plasma lipoproteins |
| Q83371087 | Cloning and expression of apolipoprotein E3 and its variant apoE2 and apoE4 |
| Q72653925 | Comparative study of four HDL-cholesterol assay methods |
| Q41836439 | Concerning the structure of apoE |
| Q37050609 | Control of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Activity in Cultured Human Fibroblasts by Very Low Density Lipoproteins of Subjects with Hypertriglyceridemia |
| Q67833601 | Determination of apolipoprotein E phenotypes from stored or postmortem serum samples |
| Q40006199 | Determination of human apolipoprotein e by electroimmunoassay |
| Q35582832 | Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. |
| Q83957058 | Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations |
| Q39744497 | Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet |
| Q40686711 | Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. |
| Q71517899 | Effect of exogenous lipids and lipoproteins on the primary immune response in vitro |
| Q39951591 | Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue |
| Q40007500 | Electron Microscopic Characterization of Lipoproteins from Patients with Familial Type III Hyperlipoproteinaemia |
| Q40187802 | Electron-microscopic evidence for particles smaller than 250 Å in very low density lipoproteins of human plasma |
| Q37556999 | Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit |
| Q37011453 | Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells |
| Q70427868 | Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis |
| Q35204503 | Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects |
| Q33669967 | Genetics of the apolipoprotein-E isoprotein system in man. |
| Q70935048 | Human apolipoprotein C-I: Concentration in blood serum and lipoproteins |
| Q35201063 | Human apolipoprotein E isoprotein subclasses are genetically determined |
| Q48390455 | Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant |
| Q70143733 | Human apolipoprotein E: polymorphism and binding domain of the receptors |
| Q40264868 | Identification and characterization of mixed disulphide complexes of e apoprotein in high density lipoprotein of subjects with acute alcoholic hepatitis |
| Q48537048 | Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide |
| Q39924098 | Identification of apolipoproteins in lipoprotein density classes of hypercholesterolemia (type IIa) |
| Q40283160 | Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency |
| Q33952285 | Immunogenetic polymorphism of lipoproteins in swine: genetic, immunological and physiochemical characterization of the two allotypes Lpr1 and Lpr2 |
| Q39681706 | Immunological relationship between bile lipoprotein complex and high density lipoprotein |
| Q28077212 | Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes |
| Q37016558 | Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia |
| Q36269808 | Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality |
| Q34360596 | Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system |
| Q39168613 | Ionization Behaviour of Native Apolipoproteins and of Their Complexes with Lecithin. 2. Potentiometric Titration of the Native ApoA-II, ApoC-I, ApoC-III Proteins and of Their Complexes with Dimyristoyl Lecithin |
| Q40245842 | Isolation and characterization of the three major low density lipoproteins from normolipidemic rhesus monkeys (Macaca mulatta) |
| Q40128892 | Isolation of a high density lipoprotein with high contents of arginine-rich apoprotein (apoE) from rat plasma |
| Q40159844 | Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation |
| Q36399400 | Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia |
| Q37038770 | Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects |
| Q40005922 | Lipid transport in the avian species Part 2. Isolation and characterization of lipoprotein a and lipoprotein B, two major lipoprotein families of the male turkey serum lipoprotein system |
| Q39659813 | Lipid-protein interactions in the plasma lipoproteins |
| Q35049469 | Lipoprotein lipase cofactor activity of a carboxyl-terminal peptide of apolipoprotein C-II |
| Q39942971 | Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins |
| Q39582081 | Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions. |
| Q39963053 | Metabolism of apoprotein B of plasma very low density lipoproteins in the rat |
| Q32027380 | Microsequencing of bovine cerebrospinal fluid apolipoproteins: identification of bovine apolipoprotein E. |
| Q34995736 | New protein in human blood plasma, rich in proline, with lipid-binding properties |
| Q37401949 | Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? |
| Q72530926 | Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients |
| Q40047187 | Physical, chemical and immunochemical characterization of a lipoprotein lipase activator protein from pig plasma very low density lipoproteins |
| Q36753584 | Plasma levels of apolipoprotein-E in residents of the European North of Russia |
| Q40098108 | Plasma lipoprotein changes in experimental cholestasis in the dog |
| Q66845744 | Plasma lipoproteins and apolipoproteins |
| Q40006191 | Platelet lipoproteins a comparative study with serum lipoproteins |
| Q39384194 | Pre-β1-lipoprotein and Lp(a) Antigen in Relation to Triglyceride Levels and Insulin Release Following an Oral Glucose Load in Middle-aged Males |
| Q40236409 | Preparative isoelectric focussing of apolipoproteins C and E from human very low density lipoproteins |
| Q42002142 | Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations. |
| Q35107934 | Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins |
| Q24561650 | Primary structure of very low density apolipoprotein C-II of human plasma |
| Q39991303 | Quantitation of apolipoprotein A-I of human plasma high density lipoprotein |
| Q72692916 | Quantitation of apolipoprotein E in rabbit sera with a competitive enzyme-linked immunosorbent assay |
| Q39992701 | Rabbits as a Model for the Study of Hyperlipoproteinemia and Atherosclerosis |
| Q40007046 | Radioimmunoassay for human plasma apolipoprotein B |
| Q40047120 | Radioimmunoassay of arginine-rich apolipoprotein of rat serum |
| Q37026434 | Radioimmunoassay studies of human apolipoprotein E. |
| Q36591500 | Rat apolipoprotein E mRNA. Cloning and sequencing of double-stranded cDNA |
| Q45083057 | Role of apolipoprotein E in renal damage protection |
| Q70976207 | Separation of human C-apolipoproteins by high-performance liquid chromatography |
| Q69428018 | Serum apolipoprotein profile of patients with chronic renal failure |
| Q24629008 | Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I |
| Q41071705 | Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins |
| Q40025837 | Some aspects of lipoprotein metabolism |
| Q40164091 | Stimulation of human erythrocyte Mg++-ATPase by plasma lipoproteins |
| Q39989664 | Studies of the hydrolyses of triacylglycerols in chylomicrons, very low- and low-density lipoproteins by C-I activated lipoprotein lipase from post-heparin plasma of normal human subjects |
| Q40023318 | Studies on Human Serum High-Density Lipoproteins: VI. Studies on a Cholesterol Ester-Releasing Reaction in Vitro |
| Q40006194 | Studies on pig serum lipoproteins III. Affinity chromatography of native lipoproteins on concanavalin A-Sepharose |
| Q39936105 | Studies on the composition of pig serum lipoproteins isolation and characterization of different apoproteins |
| Q43513619 | Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms |
| Q48390623 | Synthesis, intracellular processing, and signal peptide of human apolipoprotein E |
| Q35974993 | Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein |
| Q34289373 | The Fat‐Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture |
| Q37047755 | The Interaction of Heparin with an Apoprotein of Human Very Low Density Lipoprotein |
| Q30248596 | The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts |
| Q40109639 | The Origin and Fate of HDL |
| Q37684102 | The Plasma Lipoproteins |
| Q91559566 | The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation |
| Q46166068 | The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls |
| Q53674023 | The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice. |
| Q39579630 | The carbohydrate content of apoliprotein E from human very low density lipoproteins |
| Q33213990 | The key role of apolipoprotein E in atherosclerosis |
| Q70587571 | The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man |
| Q39983210 | The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins |
| Q45730801 | The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains. |
| Q33858831 | The potential applications of Apolipoprotein E in personalized medicine |
| Q41230852 | The proliferative response of hepatic peroxidomes of neonatal rats to treatment with SU-13 437 (nafenopin) |
| Q40104356 | The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats |
| Q27021950 | The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism |
| Q35000063 | The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I |
| Q40116357 | The turnover of human plasma very low density lipoprotein protein |
| Q71142032 | Two-dimensional immunoelectrophoresis of human serum very low density apolipoproteins |
| Q36130584 | Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice |
| Q69764265 | Value and significance of a hyperlipemia test by venous approach in the study of hyperlipemia. Study of it's variation under the effect of alcohol |
| Q51987176 | Xenopus cDNA microarray identification of genes with endodermal organ expression. |
| Q51650561 | [The apolipoproteins in man ] |
| Q72635719 | mRNA-dependent synthesis of rat apolipoprotein E in vitro: Cotranslational processing and identification of an endoglycosidase H-sensitive glycopeptide intermediate |
Search more.